http://irises.unilink.it/resource/item/18346
type: Document
type: Entity
type: Information Content Entity
type: Academic Article
label: Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 >= 50% who progress on first-line immunotherapy: real-world data from a European cohort
type: Article
related by: 5987335
most specific type: Academic Article
language: Inglese
type: Continuant
type: Thing
type: Generically Dependent Continuant

Document
type: Class

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

5987335
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: http://irises.unilink.it/resource/item/18346

Article
type: Class

individual
rights: termsOfUse
date: 2026-08-26T12:26:27
publisher: http://irises.unilink.it/resource/item/18346
type: Document
label: RDF description of Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 >= 50% who progress on first-line immunotherapy: real-world data from a European cohort - http://irises.unilink.it/resource/item/18346

Information Content Entity
type: Class

Inglese
type: Language